The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Yael A Leshem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Rabin Medical Center, Petach-Tikva, Israel. Hauptthemen laut MEDLINE: Eczema. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Core outcome sets (COS) are consensus-driven sets of minimum outcomes that should be measured and reported in all clinical trials. COS aim to reduce heterogeneity in outcome measurement and reporting, and selective outcome reporting. Implementing COS into clinical trials is challenging. Guidance to improve COS uptake in dermatology is lacking.
Objectives
To develop a structured practical guide to COS implementation.
Methods
Members of the Harmonising Outcome Measurement for Eczema (HOME) executive committee developed an expert opinion-based roadmap founded on a combination of a review of the COS implementation literature, the Core Outcome Measures in Effectiveness Trials (COMET) initiative resources, input from HOME members and experience in COS development and clinical trials.
Results
The data review and input from HOME members was synthesized into themes, which guided roadmap development: (a) barriers and facilitators to COS uptake based on stakeholder awareness/engagement and COS features; and (b) key implementation science principles (assessment-driven, data-centred, priority-based and context-sensitive). The HOME implementation roadmap follows three stages. Firstly, the COS uptake scope and goals need to be defined. Secondly, during COS development, preparation for future implementation is supported by establishing the COS as a credible evidence-informed consensus by applying robust COS development methodology, engaging multiple stakeholders, fostering sustained and global engagement, emphasizing COS ease of use and universal applicability, and providing recommendations on COS use. Thirdly, incorporating completed COS into primary (trials) and secondary (reviews) research is an iterative process starting with mapping COS uptake and stakeholders’ attitudes, followed by designing and carrying out targeted implementation projects. Main themes for implementation projects identified at HOME are stakeholder awareness/engagement; universal applicability for different populations; and improving ease-of-use by reducing administrative and study burden. Formal implementation frameworks can be used to identify implementation barriers/facilitators and to design implementation strategies. The effect of these strategies on uptake should be evaluated and implementation plans adjusted accordingly.
Conclusions
COS can improve the quality and applicability of research and, so, clinical practice but can only succeed if used and reported consistently. The HOME implementation roadmap is an extension of the original HOME roadmap for COS development and provides a pragmatic framework to develop COS implementation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Dermatology, Rabin Medical Center, Petach-Tikva, Israel.
- Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
- Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore.
- Department of Dermatology, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam Public Health, Infection and Immunity, Amsterdam, the Netherlands.
ORCID-Profile: Yael A Leshem, Christian Apfelbacher, Kim S Thomas, Michael E Jacobson, Hywel C Williams
Zitieren
APA
Leshem, Y. A., Simpson, E. L., Apfelbacher, C., Spuls, P. I., Thomas, K. S., Schmitt, J., Howells, L., Gerbens, L. A. A., Jacobson, M. E., Katoh, N., & Williams, H. C. (2023). The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad278
Vancouver
Leshem YA, Simpson EL, Apfelbacher C, Spuls PI, Thomas KS, Schmitt J, et al. The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad278
BibTeX
@article{Leshem2023,
author = {Leshem, Yael A and Simpson, Eric L and Apfelbacher, Christian and Spuls, Phyllis I and Thomas, Kim S and Schmitt, Jochen and Howells, Laura and Gerbens, Louise A A and Jacobson, Michael E and Katoh, Norito and Williams, Hywel C},
title = {The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad278}
}
EUVIMED